Sigma Planning Corp Acquires Shares of 25,525 Astera Labs, Inc. $ALAB

Sigma Planning Corp acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 25,525 shares of the company’s stock, valued at approximately $2,308,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Oliver Lagore Vanvalin Investment Group bought a new position in shares of Astera Labs during the second quarter valued at $29,000. Bernard Wealth Management Corp. bought a new position in shares of Astera Labs during the second quarter valued at $36,000. Ameritas Advisory Services LLC bought a new position in shares of Astera Labs in the second quarter valued at about $64,000. GAMMA Investing LLC lifted its position in Astera Labs by 55.7% during the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after buying an additional 284 shares in the last quarter. Finally, Harbour Investments Inc. lifted its position in Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after buying an additional 619 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs Trading Down 6.4%

Shares of NASDAQ:ALAB opened at $179.31 on Wednesday. The stock has a market capitalization of $29.80 billion, a P/E ratio of 320.20, a P/E/G ratio of 4.70 and a beta of 1.37. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The business has a 50-day moving average price of $196.79 and a two-hundred day moving average price of $138.70.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The company’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Ratings Changes

ALAB has been the topic of several research reports. Needham & Company LLC upped their price target on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price target on the stock. in a research report on Tuesday, July 22nd. Morgan Stanley upped their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a research report on Friday, August 29th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, September 2nd. Finally, Evercore ISI upped their price target on shares of Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 6th. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $168.88.

Insider Buying and Selling

In other news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director directly owned 385,863 shares of the company’s stock, valued at $66,858,482.01. This represents a 32.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of the company’s stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief executive officer directly owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This trade represents a 4.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 1,092,997 shares of company stock worth $192,231,120 over the last quarter. Insiders own 12.50% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.